Vitamin C And Cancer_ An Overview. [int J Vitam Nutr Res Suppl. 1982] - Pubmed Result
This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA
Overview
Download & View Vitamin C And Cancer_ An Overview. [int J Vitam Nutr Res Suppl. 1982] - Pubmed Result as PDF for free.
More details
- Words: 476
- Pages: 1
A service of the U.S. National Library of Medicine and the National Institutes of Health
All Databases
Search
Nucleotide
PubMed
Limits Clear Display All: 1
PubMed
Preview/Index
Protein
Genome
Structure
OMIM
My NCBI [Sign In] [Register] PMC
Journals
Books
History
Clipboard
AbstractPlus
Advanced Search
Go
for Details Show
20
Sort By
Send to
Review: 1 Links
1: Int J Vitam Nutr Res Suppl. 1982;23:115-27. Related Articles
Vitamin C and cancer: an overview.
Review Ascorbic acid and cancer: a review.
Cameron E.
[Cancer Res. 1979]
The outcome of every cancer illness is determined to a significant extent by the inherent resistance of the individual patient to his or her disease. There is increasing recognition that resistance to cancer depends, to a certain extent, upon the availability of certain nutritional factors, of which ascorbic acid appears to be the most important. Ascorbic acid protects against the destructive effects of malignant invasiveness by stabilizing the ground substance and enhancing collagen encapsulation. It is also involved in the mechanisms of both cell-mediated and humoral immunity including the production of interferon, and other factors either known or thought to be involved collectively in host resistance to neoplasia. There is also some recent evidence suggesting that ascorbate exerts a selective cytotoxic effect against malignant cells. All these observations indicate that supplemental ascorbate should be of some therapeutic value in the treatment of cancer. Clinical trials conducted over the last decade are briefly reviewed, and the balance of evidence supports this contention. It is predicted that in the not-to-distant future, supplemental ascorbate will attain an established place in all comprehensive cancer treatment regimes.
Review Overview of resistance to systemic therapy in patients with breast cancer. [Adv Exp Me dBiol. 2007] [Frontier of mycobacterium research--host vs. mycobacterium] [Kekk aku. 2005] Review Ascorbic acid and atherosclerotic cardiovascular disease. [Subcel lBiochem. 1996] Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. [P roc Natl Acad Sci U SA. 1976] » See Reviews...
|
» See All...
Patient Drug Information
PMID: 6180998 [PubMed - indexed for MEDLINE] Ascorbic Acid (Cecon® Drops, Cenolate® , Cevi-Bid® , ...) Ascorbic acid is used to prevent and treat scurvy, a disease caused by a lack of vitamin C in the body. Source: AHFS Consumer Medication Information
Recent Activity Turn Off
Clear
Vitamin C and cancer: an overview. The influence of ascorbic acid on the growth of solid tumors in mice and on tumor control ... Vitamin C lowers mutagenic and toxic effect of hexavalent chromium in guinea pigs. A case-control study of nutrient status and invasive cervical cancer. I. Dietary indicator... Antimetabolic activity of L-ascorbic acid in human and animal tumors.
Display
AbstractPlus
Show
20
Sort By
Send to
Write to the Help Desk NCBI | NLM | NIH Department of Health & Human Services Privacy Statement | Freedom of Information Act | Disclaimer
All Databases
Search
Nucleotide
PubMed
Limits Clear Display All: 1
PubMed
Preview/Index
Protein
Genome
Structure
OMIM
My NCBI [Sign In] [Register] PMC
Journals
Books
History
Clipboard
AbstractPlus
Advanced Search
Go
for Details Show
20
Sort By
Send to
Review: 1 Links
1: Int J Vitam Nutr Res Suppl. 1982;23:115-27. Related Articles
Vitamin C and cancer: an overview.
Review Ascorbic acid and cancer: a review.
Cameron E.
[Cancer Res. 1979]
The outcome of every cancer illness is determined to a significant extent by the inherent resistance of the individual patient to his or her disease. There is increasing recognition that resistance to cancer depends, to a certain extent, upon the availability of certain nutritional factors, of which ascorbic acid appears to be the most important. Ascorbic acid protects against the destructive effects of malignant invasiveness by stabilizing the ground substance and enhancing collagen encapsulation. It is also involved in the mechanisms of both cell-mediated and humoral immunity including the production of interferon, and other factors either known or thought to be involved collectively in host resistance to neoplasia. There is also some recent evidence suggesting that ascorbate exerts a selective cytotoxic effect against malignant cells. All these observations indicate that supplemental ascorbate should be of some therapeutic value in the treatment of cancer. Clinical trials conducted over the last decade are briefly reviewed, and the balance of evidence supports this contention. It is predicted that in the not-to-distant future, supplemental ascorbate will attain an established place in all comprehensive cancer treatment regimes.
Review Overview of resistance to systemic therapy in patients with breast cancer. [Adv Exp Me dBiol. 2007] [Frontier of mycobacterium research--host vs. mycobacterium] [Kekk aku. 2005] Review Ascorbic acid and atherosclerotic cardiovascular disease. [Subcel lBiochem. 1996] Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. [P roc Natl Acad Sci U SA. 1976] » See Reviews...
|
» See All...
Patient Drug Information
PMID: 6180998 [PubMed - indexed for MEDLINE] Ascorbic Acid (Cecon® Drops, Cenolate® , Cevi-Bid® , ...) Ascorbic acid is used to prevent and treat scurvy, a disease caused by a lack of vitamin C in the body. Source: AHFS Consumer Medication Information
Recent Activity Turn Off
Clear
Vitamin C and cancer: an overview. The influence of ascorbic acid on the growth of solid tumors in mice and on tumor control ... Vitamin C lowers mutagenic and toxic effect of hexavalent chromium in guinea pigs. A case-control study of nutrient status and invasive cervical cancer. I. Dietary indicator... Antimetabolic activity of L-ascorbic acid in human and animal tumors.
Display
AbstractPlus
Show
20
Sort By
Send to
Write to the Help Desk NCBI | NLM | NIH Department of Health & Human Services Privacy Statement | Freedom of Information Act | Disclaimer
